Stereotaxis, Inc. (STXS)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 02:01PM EDT. Market open.
| Previous Close | 1.9200 |
| Open | 1.9200 |
| Bid | 1.8900 x 900 |
| Ask | 1.9100 x 900 |
| Day's Range | 1.8700 - 1.9150 |
| 52 Week Range | 1.4000 - 3.2900 |
| Volume | |
| Avg. Volume | 198,014 |
| Market Cap | 160.847M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX
Stereotaxis (STXS) gets a CE mark in Europe for its GenesisX robotic system. Following this, the company also submits a 501(k) application for FDA clearance.
- Zacks
Stereotaxis (STXS) Receives European Approval for GenesisX
Stereotaxis (STXS) gains CE mark for GenesisX and plans to launch the system in 2025.
- Zacks
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of -75% and 21.02%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.